In human liver cancer, CD45−/CD90+/CD44+ cells form metastatic lesions in the lungs of immune compromised mice, and blockage of CD44 activity by an antagonizing antibody is shown to block tumor growth and metastasis [27]. The gene discussed is PTPRC; the disease is liver cancer.